3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Lymphoma, Large B-Cell, Diffuse
4
Breast Neoplasms
4
Burkitt Lymphoma
3
Uterine Cervical Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Colonic Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Teratoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Sezary Syndrome
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Recurrence
1
Interventions
Imiquimod
2
Flow Cytometry
2
Colposcopy
2
Biopsy
2
motexafin lutetium
1
Zoledronic Acid
1
Surveys and Questionnaires
1
Spectrometry, Fluorescence
1
Sodium Chloride
1
Quantitative Phase Imaging
1
Photochemotherapy
1
Omeprazole
1
Mutagenesis, Insertional
1
Multimodal Imaging
1
Microarray Analysis
1
Indomethacin
1
Immunohistochemistry
1
IRX 2
1
Geritol
1
Fluorescent Antibody Technique
1
Cyclophosphamide
1
Cryosurgery
1
Conization
1
5-aminolevulinic acid hexyl ester
1
1-phenyl-3,3-dimethyltriazene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Uterine Cervical Dysplasia
×
Microarray Analysis
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled